ABSTRACT

Detection and Characterisation Capability and Capacity for SARS-CoV-2 Variants Within the EU/EEA   [open pdf - 678KB]

From the Key Messages: "[1] In most Member States, the sequencing capacity for identification of SARS-CoV-2 [severe acute respiratory syndrome coronavirus 2] variants is below the recommendation set by the European Commission to sequence 5-10% of SARS-CoV-2 positive specimens. [2] Although the majority of the EU/EEA [European Economic Area] countries are actively investigating the emergence of SARS-CoV-2 variants, three countries are not doing so. [3] Many countries are increasing or planning to increase their sequencing capacity but have indicated the need for support from ECDC [European Centre for Disease Prevention and Control]. [4] Specific needs include support with sequencing capacities and protocols and with bioinformatics in particular. [5] For many countries, the turn-around time for PCR [polymerase chain reaction] pre-screening results shared with public health authorities is longer than 48 hours."

Publisher:
Date:
2021-02-16
Series:
Copyright:
2021 European Centre for Disease Prevention and Control. Posted here with permission. Documents are for personal use only and not for commercial profit.
Retrieved From:
European Centre for Disease Prevention and Control: https://www.ecdc.europa.eu/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations